LALPATHLAB.NS Cash Flow
Dr. Lal Path Labs Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹4.56 Bn | ₹5.35 Bn | ₹5.69 Bn | ₹6.36 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-2.87 Bn | ₹-0.24 Bn | ₹-3.03 Bn | ₹-4.22 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-2.83 Bn | ₹-4.14 Bn | ₹-3.34 Bn | ₹-2.64 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹-1.15 Bn | ₹0.97 Bn | ₹-0.68 Bn | ₹-0.50 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹3.78 Bn | ₹2.64 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from LALPATHLAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).